Phase II study of antineoplastons A10 and AS2-1 in patients with adenocarcinoma of the esophagus
Phase of Trial: Phase II
Latest Information Update: 17 Dec 2013
At a glance
- Drugs Antineoplaston A10/antineoplaston AS2-1 (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 10 Sep 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov
- 09 Apr 2008 The expected completion date for this trial is now 1 Dec 2011 according to ClinicalTrials.gov.
- 11 Aug 2005 New trial record.